875 related articles for article (PubMed ID: 9363587)
21. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex].
Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV
Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408
[TBL] [Abstract][Full Text] [Related]
22. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
Ma Y; Wong K
Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
[TBL] [Abstract][Full Text] [Related]
23. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
24. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of platelet surface glycoprotein receptor IIb/IIIa at hyperthermic temperatures.
Pasha R; Benavides M; Kottke-Marchant K; Harasaki H
Lab Invest; 1995 Sep; 73(3):403-8. PubMed ID: 7564273
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
[TBL] [Abstract][Full Text] [Related]
27. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Frojmovic MM; Wong T; Searcy GP
Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
[TBL] [Abstract][Full Text] [Related]
28. Normal ADP-induced aggregation and absence of dissociation of the membrane GP IIb-IIIa complex of intact rat platelets pretreated with EDTA.
Gachet C; Stierlé A; Ohlmann P; Lanza F; Hanau D; Cazenave JP
Thromb Haemost; 1991 Aug; 66(2):246-53. PubMed ID: 1771618
[TBL] [Abstract][Full Text] [Related]
29. [Fc receptor-dependent platelet activation results independently of glycoprotein complex IIb/IIIa].
Greinacher A; Liebenhoff U; Kiefel V; Presek P; Mueller-Eckhardt C
Beitr Infusionsther Transfusionsmed; 1994; 32():208-10. PubMed ID: 9480089
[TBL] [Abstract][Full Text] [Related]
30. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S
Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917
[TBL] [Abstract][Full Text] [Related]
31. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Kutok JL; Coller BS
Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
[TBL] [Abstract][Full Text] [Related]
32. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
Calvete JJ
Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry.
Faraday N; Goldschmidt-Clermont P; Dise K; Bray PF
J Lab Clin Med; 1994 May; 123(5):728-40. PubMed ID: 7515093
[TBL] [Abstract][Full Text] [Related]
34. Beta2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa.
Vallar L; Regnault V; Latger-Cannard V; Lecompte T
Thromb Haemost; 2001 Feb; 85(2):314-9. PubMed ID: 11246554
[TBL] [Abstract][Full Text] [Related]
35. The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.
Karczewski J; Connolly TM
Biochem Biophys Res Commun; 1997 Dec; 241(3):744-8. PubMed ID: 9434779
[TBL] [Abstract][Full Text] [Related]
36. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y
Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587
[TBL] [Abstract][Full Text] [Related]
37. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
Xiao Z; Théroux P; Frojmovic M
Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
39. A discrete sequence in a platelet integrin is involved in ligand recognition.
D'Souza SE; Ginsberg MH; Matsueda GR; Plow EF
Nature; 1991 Mar; 350(6313):66-8. PubMed ID: 2002847
[TBL] [Abstract][Full Text] [Related]
40. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]